deGast GC - Search Results

1

Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.

deGast GC, Beatty PG, Amos D, Mickelson EM, Sullivan KM, Anderson JE, Giblett ER, Appelbaum F, Storb R, Deeg HJ, et al. deGast GC, et al. Bone Marrow Transplant. 1991 Apr;7(4):293-5. Bone Marrow Transplant. 1991. PMID: 2070135 Clinical Trial.

2

Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.

DeGast GC, Mickelson EM, Beatty PG, Amos D, Sullivan KM, Schoch HG, Thomas ED, Hansen JA. DeGast GC, et al. Bone Marrow Transplant. 1992 Feb;9(2):87-90. Bone Marrow Transplant. 1992. PMID: 1533333

3

Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation.

de Gast GC, Beatty PG, Amos D, Sullivan K, Anderson JE, Thomas ED, Hansen JA. de Gast GC, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2700. Transplant Proc. 1987. PMID: 3274581 No abstract available.

4

Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.

Verdonck LF, de Graan-Hentzen YC, Dekker AW, Mudde GC, de Gast GC. Verdonck LF, et al. Bone Marrow Transplant. 1987 Jun;2(1):73-8. Bone Marrow Transplant. 1987. PMID: 2844337

5

Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.

de Gast GC, Boland GJ, Vlieger AM, de Weger RA, Verdonck LF, Zwaan FE, Jiwa NM. de Gast GC, et al. Bone Marrow Transplant. 1992 Apr;9(4):221-5. Bone Marrow Transplant. 1992. PMID: 1318140

6

Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.

Gratama JW, Verdonck LF, van der Linden JA, van Heugten JG, Kreeft HA, D'Amaro J, Zwaan FE, de Gast GC. Gratama JW, et al. Transplantation. 1986 Jun;41(6):719-24. doi: 10.1097/00007890-198606000-00011. Transplantation. 1986. PMID: 3012833

7

Cytomegalovirus immunity in allogeneic marrow grafting.

Gratama JW, Middeldorp JM, Sinnige LG, van der Meer JW, D'Amaro J, Jansen J, Zwaan FE, Brand A, de Gast GC, The TH. Gratama JW, et al. Transplantation. 1985 Nov;40(5):510-4. doi: 10.1097/00007890-198511000-00008. Transplantation. 1985. PMID: 2997951

8

Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.

Vlieger AM, Boland GJ, Jiwa NM, de Weger RA, Willemze R, de Gast GC, Falkenburg JH. Vlieger AM, et al. Bone Marrow Transplant. 1992 Apr;9(4):247-53. Bone Marrow Transplant. 1992. PMID: 1318141

9

Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir.

Verdonck LF, de Gast GC, Dekker AW, de Weger RA, Schuurman HJ, Rozenberg-Arska M. Verdonck LF, et al. Bone Marrow Transplant. 1989 Mar;4(2):187-9. Bone Marrow Transplant. 1989. PMID: 2539877

10

Influence of graft-versus-host disease prophylaxis on early T-lymphocyte regeneration following allogeneic bone marrow transplantation.

Gratama JW, Würsch AM, Nissen C, Gratwohl A, D'Amaro J, de Gast GC, van Rood JJ, Speck B. Gratama JW, et al. Br J Haematol. 1986 Feb;62(2):355-65. doi: 10.1111/j.1365-2141.1986.tb02939.x. Br J Haematol. 1986. PMID: 3511949

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters